Howard Salis (left), associate professor of biological engineering, chemical engineering and biomedical engineering at Penn State, and Grace Vezeau (right), who earned a doctorate in biological engineering from Penn State in 2021, and Lipika Gadila (not pictured), who earned a bachelor of science in chemical engineering from Penn State in 2018, developed a low-cost approach to developing human biomarker sensors.
Credit: Penn State
Penn State researchers have developed a low-cost, RNA-based technology to detect and measure biomarkers, which can help decode the body’s physiology.
The presence of protein biomarkers can indicate chronic or acute conditions, from arthritis to cancer to bacterial infections, for which conventional tests can cost anywhere from $100 to upwards of $1,000. The new technology can perform the same measurement for about a dollar.
The team published their results in Nature Communications, combining the efforts of Howard Salis, associate professor of biological engineering, chemical engineering and biomedical engineering; Grace Vezeau, who earned a doctorate in biological engineering from Penn State in 2021; and Lipika Gadila, who earned a bachelor of science in chemical engineering from Penn State in 2018.
“Right now, one test can be expensive, and they add up. With our new RNA-based technology, it’s now possible to carry out the same measurements for much less.” — Howard Salis
The results demonstrate that RNA-based sensors can be engineered to detect human biomarker proteins, including monomeric C-reactive protein, which is involved in chronic inflammatory conditions such as heart disease and arthritis, and interleukin-32 gamma, a signaling protein for acute infections like viruses or bacterial infections. According to Salis, such sensors could be used to develop devices for diagnostic testing.
“These tests can help a clinician diagnose a patient, but it’s more informative to carry out multiple biomarker measurements periodically over the span of several weeks,” Salis said. “Right now, one test can be expensive, and they add up. With our new RNA-based technology, it’s now possible to carry out the same measurements for much less.”
The technology is a combination of a cell-free expression system and engineered RNA-based sensors called riboswitches. Cell-free expression systems contain cellular machinery to read DNA and produce proteins, but they are not restricted by cell membranes and allow bulky proteins to freely enter. The riboswitches are engineered to bind to a biomarker protein and regulate the activation or repression of an observable signal. The riboswitch itself is produced inside the cell-free expression system from DNA instructions. Altogether, the cost of these materials is about a dollar per reaction.
According to Salis, this is the first time that researchers have engineered a riboswitch sensor to detect biomarker proteins. The challenge, he said, is figuring out the best DNA instructions to generate the most sensitive protein sensors.
“Past efforts to engineer such riboswitch sensors have largely relied on trial-and-error experimentation, for example, constructing and characterizing large random libraries to identify riboswitch variants — the genetic blueprints and aptamers — that work best,” Salis said. “Using a combination of thermodynamic modeling and computational optimization, we rationally designed new riboswitches that are predicted to be excellent protein sensors and then we tested them. Our design algorithm is called the Riboswitch Calculator.”
Salis and the researchers tested their new technology to detect three proteins: MS2, a small protein found in a bacterial phage, as a proof-of-principle test; and the medically relevant biomarkers human monomeric C-reactive protein and human interleukin-32 gamma. The researchers engineered 32 riboswitches, most of which successfully sensed their target proteins.
“Current assays require expensive detection reagents, expensive and bulky instruments, sample cold chain storage and distribution, and trained personnel,” Salis said. “By applying modeling and computational design, we engineered low-cost protein sensors that can be freeze-dried and rehydrated. The next step is to develop an easy-to-use device that allows researchers and clinicians to use this new technology.”
Original Article: Penn State engineers report low-cost human biomarker sensor designs
More from: Pennsylvania State University
The Latest Updates from Bing News
Go deeper with Bing News on:
Human biomarker sensor
- Meet the Two New Biomarker Candidates for Lewy Body Diseases
With several fluid biomarkers for Alzheimer’s in hand, the search is on for counterparts in Parkinson’s disease and dementia with Lewy bodies (DLB). Four new papers introduce two candidates: DOPA ...
- Genetic biomarker may predict severity of food allergy
Researchers reported for the first time that a genetic biomarker may be able to help predict the severity of food allergy reactions. Currently there is no reliable or readily available clinical ...
- Discovery of planet that can host life is a triumph, but no surprise
"If only 1 in a million planets was a host to life, there would still be around half a million life-bearing planets in this galaxy alone." ...
- Life elsewhere will someday be possible
This week's real news is the discovery of life on another planet. As Cambridge University's Nikku Madhusudhan said in the first sentence of his report: "The search for habitable environments and ...
- Identification of Accessible Human Cancer Biomarkers Using Ex Vivo Chemical Proteomic Strategies
Most current strategies for biomarker identification from cells ... Chemical protein modifications by ex vivo perfusion of resected human cancer-bearing organs provide an approach for the ...
Go deeper with Bing News on:
- Sensor Based Dehumidifier System For Your Home
He combined a set of wireless sensors and remote control outlets to ... could compare temperature with dew point and make decisions based on a simple look-up table. An Arduino with a custom ...
- In a Major Breakthrough, Intact RNA is Recovered From Extinct Animal
When scientists are working with RNA in the lab, they have to take a lot of precautions because RNA degrades so easily. When tissue specimens are used for RNA extraction, they are typically used ...
- Thesis: A glow-in-the-dark test for disease diagnosis
TU/e researcher Eva van Aalen has developed a glow-in-the-dark test that can make disease diagnosis by general practitioners or in hospitals faster. This test could potentially also be used by ...
- RNA Based Therapeutics Market Size, Current Insights and Demographic Trends 2023-2030
The RNA Based Therapeutics Market Insights of 2023 is an extensive and comprehensive report that provides a complete analysis of the market's size, shares, revenues, various segments, drivers ...
- RNA Therapeutics Market worth $18.0 billion | MarketsandMarkets
Breakthroughs in mRNA vaccine technology, exemplified by the rapid development of COVID-19 vaccines, have catapulted RNA-based therapies into the spotlight. This momentum is expected to continue ...